Optiscan Imaging Ltd (OIL) - Total Assets

Latest as of June 2025: AU$10.56 Million AUD ≈ $7.47 Million USD

Based on the latest financial reports, Optiscan Imaging Ltd (OIL) holds total assets worth AU$10.56 Million AUD (≈ $7.47 Million USD) as of June 2025. Total assets represent everything the company owns and controls, combining both current assets—like cash and cash equivalents, accounts receivable, and inventories—and non-current assets such as property, plant, equipment (PP&E), intangible assets, and long-term investments. See OIL net assets for net asset value and shareholders' equity analysis.

Optiscan Imaging Ltd - Total Assets Trend (1998–2025)

This chart illustrates how Optiscan Imaging Ltd's total assets have evolved over time, based on quarterly financial data.

Optiscan Imaging Ltd - Asset Composition Analysis

Current Asset Composition (June 2025)

Optiscan Imaging Ltd's total assets of AU$10.56 Million consist of 84.0% current assets and 16.0% non-current assets.

Asset Category Amount (AUD) % of Total Assets
Cash & Equivalents AU$4.55 Million 43.1%
Accounts Receivable AU$316.55K 3.0%
Inventory AU$1.67 Million 15.9%
Property, Plant & Equipment AU$1.69 Million 16.0%
Intangible Assets AU$4.70K 0.0%
Goodwill AU$0.00 0.0%

Asset Composition Trend (1998–2025)

This chart illustrates how Optiscan Imaging Ltd's asset composition has evolved over time. Understanding changes in asset allocation can provide insights into the company's strategic shifts, capital allocation priorities, and business focus evolution. For live market cap, price, and company overview, see how much is Optiscan Imaging Ltd worth.

Key Asset Composition Facts

  • Current vs. Non-Current Assets: Optiscan Imaging Ltd's current assets represent 84.0% of total assets in 2025, an increase from 26.1% in 1998.
  • Cash Position: Cash and equivalents constituted 43.1% of total assets in 2025, up from 22.8% in 1998.
  • Tangible vs. Intangible: Intangible assets (including goodwill) make up 0.0% of total assets, a decrease from 142.0% in 1998.
  • Asset Diversification: The largest asset category is cash and equivalents at 43.1% of total assets.

Optiscan Imaging Ltd Competitors by Total Assets

Key competitors of Optiscan Imaging Ltd based on total assets are shown below.

Company Country Total Assets
Shenzhen Everbest Machinery Indus
SHE:002980
China CN¥1.46 Billion
Goldcard High-Tech Co Ltd
SHE:300349
China CN¥7.07 Billion
Orexplore Technologies Ltd
AU:OXT
Australia AU$10.11 Million
Codan Ltd
AU:CDA
Australia AU$904.80 Million
Catapult Group International Ltd
AU:CAT
Australia AU$218.31 Million
Ikegps Group Ltd
AU:IKE
Australia AU$51.01 Million
Structural Monitoring Systems Plc
AU:SMN
Australia AU$34.67 Million
Dorsavi Ltd
AU:DVL
Australia AU$3.97 Million

Optiscan Imaging Ltd - Liquidity and Working Capital Analysis

Liquidity ratios measure a company's ability to pay off its short-term debts as they come due, using the company's current or quick assets. Working capital represents the operational liquidity available.

Key Liquidity Metrics

Metric Current 1 Year Ago 5 Years Ago
Current Ratio 5.87 8.59 2.02
Quick Ratio 4.76 7.45 1.09
Cash Ratio 3.02 3.48 0.42
Working Capital AU$7.35 Million AU$13.31 Million AU$1.26 Million

Optiscan Imaging Ltd - Advanced Valuation Insights

This section examines the relationship between Optiscan Imaging Ltd's asset base and its market valuation, helping to identify whether the company's assets are efficiently translated into market value.

Key Valuation Metrics

Current Price-to-Book Ratio 11.51
Latest Market Cap to Assets Ratio 7.70
Asset Growth Rate (YoY) -32.5%
Total Assets AU$10.56 Million
Market Capitalization $81.27 Million USD

Valuation Analysis

Premium Asset Valuation: The market values Optiscan Imaging Ltd's assets at a significant premium (7.70x), suggesting investors see substantial growth potential or unique competitive advantages.

Significant Asset Reduction: Optiscan Imaging Ltd's assets decreased by 32.5% over the past year, potentially indicating divestiture, restructuring, or challenging business conditions.

Annual Total Assets for Optiscan Imaging Ltd (1998–2025)

The table below shows the annual total assets of Optiscan Imaging Ltd from 1998 to 2025.

Year Total Assets Change
2025-06-30 AU$10.56 Million
≈ $7.47 Million
-32.47%
2024-06-30 AU$15.63 Million
≈ $11.06 Million
+234.55%
2023-06-30 AU$4.67 Million
≈ $3.31 Million
-41.48%
2022-06-30 AU$7.98 Million
≈ $5.65 Million
-31.74%
2021-06-30 AU$11.70 Million
≈ $8.28 Million
+239.54%
2020-06-30 AU$3.44 Million
≈ $2.44 Million
-5.48%
2019-06-30 AU$3.64 Million
≈ $2.58 Million
-11.76%
2018-06-30 AU$4.13 Million
≈ $2.92 Million
+54.88%
2017-06-30 AU$2.67 Million
≈ $1.89 Million
+46.46%
2016-06-30 AU$1.82 Million
≈ $1.29 Million
+78.83%
2015-06-30 AU$1.02 Million
≈ $720.45K
+24.73%
2014-06-30 AU$816.35K
≈ $577.62K
-45.95%
2013-06-30 AU$1.51 Million
≈ $1.07 Million
+27.93%
2012-06-30 AU$1.18 Million
≈ $835.40K
-46.32%
2011-06-30 AU$2.20 Million
≈ $1.56 Million
+0.33%
2010-06-30 AU$2.19 Million
≈ $1.55 Million
-23.78%
2009-06-30 AU$2.88 Million
≈ $2.04 Million
-68.84%
2008-06-30 AU$9.23 Million
≈ $6.53 Million
-20.46%
2007-06-30 AU$11.60 Million
≈ $8.21 Million
-3.12%
2006-06-30 AU$11.98 Million
≈ $8.48 Million
-16.93%
2005-06-30 AU$14.42 Million
≈ $10.20 Million
+5.13%
2004-06-30 AU$13.72 Million
≈ $9.70 Million
-29.00%
2003-06-30 AU$19.32 Million
≈ $13.67 Million
-12.37%
2002-06-30 AU$22.04 Million
≈ $15.60 Million
+61.43%
2001-06-30 AU$13.66 Million
≈ $9.66 Million
-25.19%
2000-06-30 AU$18.25 Million
≈ $12.92 Million
+127.15%
1999-06-30 AU$8.04 Million
≈ $5.69 Million
-4.29%
1998-06-30 AU$8.40 Million
≈ $5.94 Million
--

About Optiscan Imaging Ltd

AU:OIL Australia Scientific & Technical Instruments
Market Cap
$81.27 Million
AU$114.86 Million AUD
Market Cap Rank
#19986 Global
#680 in Australia
Share Price
AU$0.11
Change (1 day)
+0.00%
52-Week Range
AU$0.08 - AU$0.15
All Time High
AU$0.45
About

Optiscan Imaging Limited engages in the development, manufacture, and commercialization of endomicroscopic digital imaging technology solutions for medical, translational, and pre-clinical applications in Germany, China, Australia, and the United States. It offers InVue, a microscopic medical imaging device for precision surgery; InForm, a digital pathology imaging device for pathology workflows;… Read more